DAPAONE 10MG

About

DAPAONE 10MG contains dapagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor. This medication works by blocking the reabsorption of glucose in the kidneys, leading to increased excretion of glucose in the urine. This mechanism helps to lower blood glucose levels independently of insulin secretion and sensitivity, making it an effective treatment for type 2 diabetes.

In addition to its primary role in glycemic control, dapagliflozin has demonstrated significant benefits beyond blood sugar reduction. Clinical studies have shown that it can reduce the risk of cardiovascular death and hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors. It also offers renal protective effects, slowing the progression of kidney disease in certain patients.

Uses

• Management of type 2 diabetes mellitus.
• As an adjunct to diet and exercise.
• To reduce the risk of cardiovascular death and hospitalization for heart failure.
• To reduce the risk of kidney disease progression.

Directions For Use

Take DAPAONE 10MG orally once daily, preferably in the morning, with or without food, as directed by your doctor.

Benefits

• Effective reduction in blood glucose and HbA1c.
• Promotes weight loss.
• Lowers blood pressure.
• Reduces risk of major adverse cardiovascular events.
• Provides significant renal protection.
• Low risk of hypoglycemia when used alone.

Side Effects

• Genital mycotic infections
• Urinary tract infections
• Increased urination
• Thirst
• Dizziness
• Dehydration
• Hypotension
• Back pain
• Nausea
• Ketoacidosis (rare)
• Fournier's gangrene (rare)
• Hypoglycemia (when combined with insulin/sulfonylurea)

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of dehydration and ketoacidosis, especially in susceptible individuals.
• Pregnancy - Not recommended during the second and third trimesters of pregnancy. Discuss with your doctor if you are pregnant or planning to conceive.
• Breastfeeding - Avoid use while breastfeeding as it may pass into breast milk and potentially harm the infant.
• Liver - Generally safe for use in mild to moderate liver impairment; however, caution is advised in severe hepatic dysfunction.
• Kidney - Dose adjustment or discontinuation is necessary based on eGFR. Not recommended for patients with severe renal impairment or on dialysis.
• Lung - No specific contraindications related to lung conditions, but ensure adequate hydration, especially in patients with respiratory illness.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.